These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 30674563)
1. Facilitation of Furutani K; Tsumoto K; Chen IS; Handa K; Yamakawa Y; Sack JT; Kurachi Y J Gen Physiol; 2019 Feb; 151(2):214-230. PubMed ID: 30674563 [TBL] [Abstract][Full Text] [Related]
2. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel. Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182 [TBL] [Abstract][Full Text] [Related]
3. Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells. De Waard S; Montnach J; Ribeiro B; Nicolas S; Forest V; Charpentier F; Mangoni ME; Gaborit N; Ronjat M; Loussouarn G; Lemarchand P; De Waard M Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998413 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Possible Proarrhythmic Potency: Comparison of the Effect of Dofetilide, Cisapride, Sotalol, Terfenadine, and Verapamil on hERG and Native IKr Currents and on Cardiac Action Potential. Orvos P; Kohajda Z; Szlovák J; Gazdag P; Árpádffy-Lovas T; Tóth D; Geramipour A; Tálosi L; Jost N; Varró A; Virág L Toxicol Sci; 2019 Apr; 168(2):365-380. PubMed ID: 30561737 [TBL] [Abstract][Full Text] [Related]
5. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides. Spector PS; Curran ME; Keating MT; Sanguinetti MC Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709 [TBL] [Abstract][Full Text] [Related]
6. Molecular interaction of droperidol with human ether-a-go-go-related gene channels: prolongation of action potential duration without inducing early afterdepolarization. Schwoerer AP; Blütner C; Brandt S; Binder S; Siebrands CC; Ehmke H; Friederich P Anesthesiology; 2007 May; 106(5):967-76. PubMed ID: 17457128 [TBL] [Abstract][Full Text] [Related]
7. Modulation of HERG potassium channel function by drug action. Thomas D; Karle CA; Kiehn J Ann Med; 2004; 36 Suppl 1():41-6. PubMed ID: 15176423 [TBL] [Abstract][Full Text] [Related]
8. High affinity open channel block by dofetilide of HERG expressed in a human cell line. Snyders DJ; Chaudhary A Mol Pharmacol; 1996 Jun; 49(6):949-55. PubMed ID: 8649354 [TBL] [Abstract][Full Text] [Related]
9. Facilitation of hERG Activation by Its Blocker: A Mechanism to Reduce Drug-Induced Proarrhythmic Risk. Furutani K Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003453 [TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of block and facilitation of HERG current by a class III anti-arrhythmic agent, nifekalant. Hosaka Y; Iwata M; Kamiya N; Yamada M; Kinoshita K; Fukunishi Y; Tsujimae K; Hibino H; Aizawa Y; Inanobe A; Nakamura H; Kurachi Y Channels (Austin); 2007; 1(3):198-208. PubMed ID: 18690032 [TBL] [Abstract][Full Text] [Related]
11. The human ether-a-go-go-related gene (hERG) current inhibition selectively prolongs action potential of midmyocardial cells to augment transmural dispersion. Yasuda C; Yasuda S; Yamashita H; Okada J; Hisada T; Sugiura S J Physiol Pharmacol; 2015 Aug; 66(4):599-607. PubMed ID: 26348084 [TBL] [Abstract][Full Text] [Related]
12. Molecular determinants of dofetilide block of HERG K+ channels. Ficker E; Jarolimek W; Kiehn J; Baumann A; Brown AM Circ Res; 1998 Feb; 82(3):386-95. PubMed ID: 9486667 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action. Kushida S; Ogura T; Komuro I; Nakaya H Eur J Pharmacol; 2002 Dec; 457(1):19-27. PubMed ID: 12460639 [TBL] [Abstract][Full Text] [Related]
14. Open channel block by KCB-328 [1-(2-amino-4-methanesulfonamidophenoxy)-2-[N-(3,4-dimethoxyphenethyl)-N-methylamino]ethane hydrochloride] of the heterologously expressed human ether-a-go-go-related gene K+ channels. Park JB; Choe H; Lee YK; Ha KC; Rhee KS; Ko JK; Joo CU; Chae SW; Kwak YG J Pharmacol Exp Ther; 2002 Jul; 302(1):314-9. PubMed ID: 12065732 [TBL] [Abstract][Full Text] [Related]
15. Acidification alters antiarrhythmic drug blockade of the ether-a-go-go-related Gene (HERG) Channels. Dong DL; Li Z; Wang HZ; Du ZM; Song WH; Yang BF Basic Clin Pharmacol Toxicol; 2004 May; 94(5):209-12. PubMed ID: 15125690 [TBL] [Abstract][Full Text] [Related]
16. IKr channel blockers: novel antiarrhythmic agents. Lee K; Park JY; Ryu PD; Kwon LS; Kim HY Curr Med Chem Cardiovasc Hematol Agents; 2003 Oct; 1(3):203-23. PubMed ID: 15326913 [TBL] [Abstract][Full Text] [Related]
17. Block of HERG-carried K+ currents by the new repolarization delaying agent H 345/52. Amos GJ; Jacobson I; Duker G; Carlsson L J Cardiovasc Electrophysiol; 2003 Jun; 14(6):651-8. PubMed ID: 12875428 [TBL] [Abstract][Full Text] [Related]
18. Block of hERG K+ channel and prolongation of action potential duration by fluphenazine at submicromolar concentration. Hong HK; Lee BH; Park MH; Lee SH; Chu D; Kim WJ; Choe H; Hee Choi B; Jo SH Eur J Pharmacol; 2013 Feb; 702(1-3):165-73. PubMed ID: 23395964 [TBL] [Abstract][Full Text] [Related]
19. The hERG channel activator, RPR260243, enhances protective Shi YP; Pang Z; Venkateshappa R; Gunawan M; Kemp J; Truong E; Chang C; Lin E; Shafaattalab S; Faizi S; Rayani K; Tibbits GF; Claydon VE; Claydon TW Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H251-H261. PubMed ID: 32559136 [TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a compound that protects cardiac tissue from human Ether-à-go-go-related gene (hERG)-related drug-induced arrhythmias. Potet F; Lorinc AN; Chaigne S; Hopkins CR; Venkataraman R; Stepanovic SZ; Lewis LM; Days E; Sidorov VY; Engers DW; Zou B; Afshartous D; George AL; Campbell CM; Balser JR; Li M; Baudenbacher FJ; Lindsley CW; Weaver CD; Kupershmidt S J Biol Chem; 2012 Nov; 287(47):39613-25. PubMed ID: 23033485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]